Cutter & CO Brokerage, Inc. Heron Therapeutics, Inc. Transaction History

Cutter & CO Brokerage, Inc.

$393 Million
Q1 2025

A detailed history of Cutter & CO Brokerage, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 36,465 shares of HRTX stock, worth $65,272. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,465

Previous 33,135 10.05%

Holding current value

$65,272

Previous $50,000 60.0%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$1.47 - $2.55 $4,895 - $8,491	3,330 Added 10.05%	36,465 $80,000
Q4 2024 Feb 04, 2025	BUY	$1.06 - $2.12 $14,416 - $28,832	13,600 Added 69.62%	33,135 $50,000
Q3 2024 Oct 25, 2024	BUY	$1.73 - $3.67 $33,795 - $71,693	19,535 New	19,535 $38,000
Q2 2023 Aug 01, 2023	SELL	$1.11 - $2.88 $1,537 - $3,988	-1,385 Reduced 11.98%	10,180 $11,000
Q1 2023 May 09, 2023	SELL	$1.51 - $3.25 $1,645 - $3,542	-1,090 Reduced 8.61%	11,565 $17,000
Q4 2022 Feb 03, 2023	SELL	$2.25 - $4.67 $562 - $1,167	-250 Reduced 1.94%	12,655 $31,000
Q3 2022 Nov 03, 2022	SELL	$2.66 - $5.37 $532 - $1,074	-200 Reduced 1.53%	12,905 $54,000
Q2 2022 Jul 28, 2022	SELL	$2.3 - $6.29 $632 - $1,729	-275 Reduced 2.06%	13,105 $37,000
Q1 2022 May 03, 2022	SELL	$4.63 - $9.94 $13,635 - $29,273	-2,945 Reduced 18.04%	13,380 $77,000
Q4 2021 Feb 10, 2022	SELL	$8.35 - $12.6 $121,158 - $182,826	-14,510 Reduced 47.06%	16,325 $149,000
Q3 2021 Nov 02, 2021	BUY	$10.13 - $15.0 $24,008 - $35,550	2,370 Added 8.33%	30,835 $330,000
Q2 2021 Aug 09, 2021	BUY	$13.27 - $18.48 $8,293 - $11,550	625 Added 2.24%	28,465 $442,000
Q1 2021 May 11, 2021	SELL	$14.49 - $20.72 $79,695 - $113,960	-5,500 Reduced 16.5%	27,840 $451,000
Q4 2020 Feb 03, 2021	BUY	$14.61 - $22.14 $41,784 - $63,320	2,860 Added 9.38%	33,340 $706,000
Q3 2020 Nov 05, 2020	BUY	$13.67 - $17.77 $3,759 - $4,886	275 Added 0.91%	30,480 $452,000
Q2 2020 Aug 10, 2020	BUY	$10.89 - $21.47 $5,227 - $10,305	480 Added 1.61%	30,205 $444,000
Q1 2020 May 05, 2020	BUY	$10.23 - $24.56 $10,639 - $25,542	1,040 Added 3.63%	29,725 $349,000
Q4 2019 Feb 11, 2020	BUY	$17.42 - $26.61 $107,568 - $164,316	6,175 Added 27.43%	28,685 $674,000
Q3 2019 Nov 07, 2019	BUY	$16.36 - $21.39 $23,558 - $30,801	1,440 Added 6.83%	22,510 $416,000
Q2 2019 Jul 31, 2019	BUY	$16.93 - $26.22 $108,605 - $168,201	6,415 Added 43.77%	21,070 $392,000
Q1 2019 Apr 23, 2019	BUY	$23.15 - $28.34 $75,700 - $92,671	3,270 Added 28.72%	14,655 $358,000
Q2 2018 Jul 30, 2018	BUY	$26.4 - $42.0 $20,196 - $32,130	765 Added 7.2%	11,385 $442,000
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $195,726 - $305,856	10,620 New	10,620 $293,000

Others Institutions Holding HRTX

# of Institutions

185

Shares Held

126M

Call Options Held

847K

Put Options Held

47.7K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $213M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.

Account

Cutter & CO Brokerage, Inc. Heron Therapeutics, Inc. Transaction History